Literature DB >> 27591076

MIF-driven activation of macrophages induces killing of intracellular Trypanosoma cruzi dependent on endogenous production of tumor necrosis factor, nitric oxide and reactive oxygen species.

Romina A Cutrullis1, Patricia B Petray2, Ricardo S Corral3.   

Abstract

The proinflammatory cytokine macrophage migration inhibitory factor (MIF) is a key player in innate immunity. MIF has been considered critical for controlling acute infection by the protozoan Trypanosoma cruzi, but the underlying mechanisms are poorly understood. Our study aimed to analyze whether MIF could favor microbicidal activity of the macrophage, a site where T. cruzi grows and the initial effector cell against this parasite. Using murine macrophages infected in vitro, we examined the effect of MIF on their parasiticidal ability and attempted to identify inflammatory agents involved in MIF-induced protection. Our findings show that MIF is readily secreted from peritoneal macrophages upon T. cruzi infection. MIF activates both primary and J774 phagocytes boosting the endogenous production of tumor necrosis factor-alpha via mitogen-activated protein kinase p38 signaling, as well as the release of nitric oxide and reactive oxygen species, leading to enhanced pathogen elimination. MIF can also potentiate the effect of interferon-gamma on T. cruzi killing by J774 and mouse peritoneal macrophages, rendering these cells more competent in reducing intracellular parasite burden. The present results unveil a novel innate immune pathway that contributes to host defense and broaden our understanding of the regulation of inflammatory mediators implicated in early parasite containment that is decisive for resistance to T. cruzi infection.
Copyright © 2016 Elsevier GmbH. All rights reserved.

Entities:  

Keywords:  Macrophage activation; Macrophage migration inhibitory factor; Nitric oxide; Parasiticidal activity; Reactive oxygen species; Trypanosoma cruzi infection; Tumor necrosis factor

Mesh:

Substances:

Year:  2016        PMID: 27591076     DOI: 10.1016/j.imbio.2016.08.007

Source DB:  PubMed          Journal:  Immunobiology        ISSN: 0171-2985            Impact factor:   3.144


  6 in total

Review 1.  The Role of MIF and IL-10 as Molecular Yin-Yang in the Modulation of the Host Immune Microenvironment During Infections: African Trypanosome Infections as a Paradigm.

Authors:  Benoit Stijlemans; Maxime Schoovaerts; Patrick De Baetselier; Stefan Magez; Carl De Trez
Journal:  Front Immunol       Date:  2022-04-07       Impact factor: 8.786

2.  Bladder Oxidative Stress and HMGB1 Release Contribute to PAR4-Mediated Bladder Pain in Mice.

Authors:  Shaojing Ye; Fei Ma; Dlovan F D Mahmood; Katherine L Meyer-Siegler; Lin Leng; Richard Bucala; Pedro L Vera
Journal:  Front Syst Neurosci       Date:  2022-05-13

Review 3.  Trypanosoma cruzi Evades the Complement System as an Efficient Strategy to Survive in the Mammalian Host: The Specific Roles of Host/Parasite Molecules and Trypanosoma cruzi Calreticulin.

Authors:  Galia Ramírez-Toloza; Arturo Ferreira
Journal:  Front Microbiol       Date:  2017-09-01       Impact factor: 5.640

Review 4.  ROS and Trypanosoma cruzi: Fuel to infection, poison to the heart.

Authors:  Claudia N Paiva; Emiliano Medei; Marcelo T Bozza
Journal:  PLoS Pathog       Date:  2018-04-19       Impact factor: 6.823

5.  IL-10-Dependent and -Independent Mechanisms Are Involved in the Cardiac Pathology Modulation Mediated by Fenofibrate in an Experimental Model of Chagas Heart Disease.

Authors:  Jimena Rada; Martín Donato; Federico N Penas; Catalina Alba Soto; Ágata C Cevey; Azul V Pieralisi; Ricardo Gelpi; Gerardo A Mirkin; Nora B Goren
Journal:  Front Immunol       Date:  2020-09-24       Impact factor: 7.561

6.  Oral Administration of Lactobacillus Casei Expressing Flagellin A Protein Confers Effective Protection against Aeromonas Veronii in Common Carp, Cyprinus Carpio.

Authors:  Jia-Xin Tian; Yuan-Huan Kang; Guo-Sheng Chu; Hong-Jian Liu; Yi-Di Kong; Lin-Hui Zhao; Yu-Xin Kong; Xiao-Feng Shan; Gui-Qin Wang
Journal:  Int J Mol Sci       Date:  2019-12-19       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.